Inner retinal layer thickness reflects plasma biomarkers in preclinical Alzheimer’s disease - Takeaways - MDSpire

Inner retinal layer thickness reflects plasma biomarkers in preclinical Alzheimer’s disease

  • By

  • Jane W. Chan

  • Ziyuan Wang

  • Emily Xu

  • Ibrahim Abboud

  • Aya Alhasany

  • Sophia Xu

  • Xiaomeng Wu

  • Natalie Astraea

  • Fei Jiang

  • Zhihong Jewel Hu

  • May 18, 2026

  • 0 min

Share

  • 1

    This pilot study explores the correlation between retinal layer thickness and plasma biomarkers in cognitively normal adults at risk for Alzheimer's disease.

  • 2

    Thinner inner nuclear layer (INL) and ganglion cell layer (GCL) measurements are associated with higher levels of p-tau217 and GFAP.

  • 3

    Spectral-domain optical coherence tomography (SD-OCT) provides non-invasive, layer-specific retinal measurements relevant to Alzheimer's disease.

  • 4

    The study emphasizes the need for larger, longitudinal studies to validate preliminary findings on retinal thickness and plasma biomarkers.

  • 5

    Current plasma biomarkers, while valuable, may not fully capture the early changes detectable through retinal imaging in Alzheimer's disease.

Original Source(s)

Inner retinal layer thickness reflects plasma biomarkers in preclinical Alzheimer’s disease

  • by Jane W. Chan, Ziyuan Wang, Emily Xu, Ibrahim Abboud, Aya Alhasany, Sophia Xu, Xiaomeng Wu, Natalie Astraea, Fei Jiang, Zhihong Jewel Hu

  • May 18, 2026

Related Content

Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort

Impact of Anterior Retina Ablation on Anatomical Structures in Small Animal Models

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.